Management of a Rare Lymphoepithelial Carcinoma of the Submandibular Gland in Elderly

Sairin, Mohd Eksan; Yahya, Nurlia; Kuan, Chew Yok; Yunus, Mohd Razif Mohamad; Abdullah, Mohamad Khir

doi:10.1007/s12070-015-0940-6

Indian J Otolaryngol Head Neck Surg

2015

DOI: 10.1007/s12070-015-0940-6

|View full text |Cite

Management of a Rare Lymphoepithelial Carcinoma of the Submandibular Gland in Elderly

Mohd Eksan Sairin¹,

Nurlia Yahya²,

Chew Yok Kuan³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cases of this neoplasm accounted for 0.4% of salivary gland tumor. 2 Fine needle aspiration biopsy is a gold standard in the diagnostic of salivary gland tumors. However, according to the literature, fine needle aspiration biopsy showed a sensitivity and a specificity 41.7% to 92.8% and 93.9% to 98.5%, respectively.…”

mentioning

confidence: 99%

Regarding the “Is Surgery an Inevitable Treatment for Advanced Salivary Lymphoepithelial Carcinoma? Three Case Reports”

Tretiakow

Skorek

2020

Ear Nose Throat J

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Regarding the “Is Surgery an Inevitable Treatment for Advanced Salivary Lymphoepithelial Carcinoma? Three Case Reports”

Tretiakow

Skorek

2020

Ear Nose Throat J

View full text Add to dashboard Cite

show abstract

Lymphoepithelial carcinoma of the submandibular gland in a Japanese male: A case report

Yoshida,

Watanabe,

Hiratsuka

2024

Radiology Case Reports

View full text Add to dashboard Cite

Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study

Chen

Fang

et al. 2022

BMC Pulm Med

View full text Add to dashboard Cite

Background Lymphoepithelioma-like carcinoma (LELC) is a rare and unique subtype of cancer that histologically resembles undifferentiated nasopharyngeal carcinoma (NPC). The population-based analysis of LELC and the optimal treatment remains unclear. Materials and methods This real-world, retrospective study investigated 770 patients with LELC for primary site, treatment, and survival outcomes from 2005 to 2019 from five cancer centres in China. The overall survival (OS) of different subgroups was appraised by log-rank tests and Kaplan–Meier analysis. Results Primary sites LELC included the lung (597 cases, 77.5%), salivary gland (115 cases, 14.9%), and others. The median progression-free survival (PFS) of LELC patients was 47.4 months. The median overall survival (OS) was not reached. The 5-year survival rate for LELC patients was 77.8%. Most patients in stages I and II received surgery. The majority of patients in stage III received surgery and radiotherapy. More than half of the patients in stage IV received chemotherapy. Among relapsed or metastatic cases receiving chemotherapy, patients who received immunotherapy at any time presented with a superior OS than those without immunotherapy (P < 0.0001, HR = 0.39, 95% CI 0.25–0.63). Compared with the SEER database, patients with LELC had a better prognosis than NPC, with a 5-year overall survival of 77.3% vs. 56.8% (P < 0.001). Conclusion Our data provide treatment patterns and outcomes for LELC from various primary sites. Randomized controlled studies are necessary to further define the standard of care for patients with LELC. Trial registration This clinical trial was registered at ClinicalTrials.gov (No. NCT04614818).

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Management of a Rare Lymphoepithelial Carcinoma of the Submandibular Gland in Elderly

Cited by 3 publications

References 6 publications

Regarding the “Is Surgery an Inevitable Treatment for Advanced Salivary Lymphoepithelial Carcinoma? Three Case Reports”

Regarding the “Is Surgery an Inevitable Treatment for Advanced Salivary Lymphoepithelial Carcinoma? Three Case Reports”

Lymphoepithelial carcinoma of the submandibular gland in a Japanese male: A case report

Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study

Contact Info

Product

Resources

About